1. Quinn TC. Epidemiology of HIV infections: international and U.S. perspectives.Hopkins HIV Rep.1998;10(3):11-12.
2. NBC News. Ancestry of HIV Virus Traced. Available at https://www.nbcnews.com/health/health-news/ancestry-hiv-virus-traced-flna1c9478920. Last accessed February 16, 2023.
3. Centers for Disease Control and Prevention. HIV-2 infection surveillance—United States, 1987–2009.MMWR.2011;60(29):985-988.
5. UNAIDS. Fact Sheet 2022: Global HIV Statistics. Available at https://www.unaids.org/sites/default/files/media_asset/UNAIDS_FactSheet_en.pdf. Last accessed February 16, 2023.
6. Center for Global Development. Next Steps for U.S. Africa Policy: A Debrief of President Bush's Trip to Africa. Available at https://www.cgdev.org/event/next-steps-us-africa-policy-debrief-president-bushs-trip-africa. Last accessed February 16, 2023.
7. U.S. Department of State. About Us - PEPFAR. Available at https://www.state.gov/about-us-pepfar/. Last accessed February 16, 2023.
8. Centers for Disease Control and Prevention. New Hope for Stopping HIV: Testing and Medical Care Save Lives. Available athttps://www.cdc.gov/vitalsigns/HIVTesting. Last accessed February 16, 2023.
9. Centers for Disease Control and Prevention. HIV Testing. Available athttps://www.cdc.gov/vitalsigns/hiv-testing/index.html. Last accessed February 16, 2023.
10. Centers for Disease Control and Prevention. Diagnoses of HIV Infection in the United States and Dependent Areas, 2020. Available at https://www.cdc.gov/hiv/library/reports/hiv-surveillance/vol-33/index.html. Last accessed February 16, 2023.
11. Centers for Disease Control and Prevention. Incorporating HIV prevention into the medical care of persons living with HIV.MMWR.2003;52(RR12):1-24.
12. The White House, 2021.National HIV/AIDS Strategy for the United States2022-2025. Washington, DC.
13. Centers for Disease Control and Prevention. CDC-Developed Breakthrough Technology Allows Clearest Picture to Date of HIV Infections in the U.S.: A Methods Discussion. Available athttps://www2c.cdc.gov/podcasts/media/pdf/HIV_Breakthrough.pdf. Last accessed February 16, 2023.
14. Centers for Disease Control and Prevention. Press Release: National HIV Prevention Conference Echoes Themes of HHS New HIV Prevention Initiative. Available athttps://www.cdc.gov/media/pressrel/r030728.htm. Last accessed February 16, 2023.
15. 15. CDC Fact Sheet: New HIV Infections in the United States. Available athttps://www.cdc.gov/nchhstp/newsroom/docs/factsheets/new-hiv-infections-508.pdf. Last accessed February 16, 2023.
16. MedlinePlus. HIV Screening Test. Available athttps://medlineplus.gov/lab-tests/hiv-screening-test/#top. Last accessed February 16, 2023.
17. UNAIDS. HIV and AIDS – Basic Facts. Available athttps://www.unaids.org/en/frequently-asked-questions-about-hiv-and-aids. Last accessed February 16, 2023.
18. Wagner KD, Hardin-Pierce MG, Welsh D.High-Acuity Nursing.7th ed. Upper Saddle River, NJ: Prentice Hall; 2018.
19. Centers for Disease Control and Prevention. HIV Transmission. Available athttps://www.cdc.gov/hiv/basics/transmission.html. Last accessed February 16, 2023.
20. Giannou FK, Tsiara CG, Nikolopoulos GK, et al. Condom effectiveness in reducing heterosexual HIV transmission: a systematic review and meta-analysis of studies on HIV serodiscordant couples.Expert Rev Pharmacoecon Outcomes Res.2016;16(4):489-499.
21. Carey RF, Herman WA, Retta SM, Rinaldi JE, Herman BA, Athey TW. Effectiveness of latex condoms as a barrier to human immunodeficiency virus-sized particles under the conditions of simulated use.Sex Transm Dis.1992;19(4):230-234.
22. Henry J. Kaiser Family Foundation. Crystal Meth Use Fuels Rise in HIV Cases Among White MSM; "Down Low" Term Should Apply To All Races, Studies Say. Available athttps://khn.org/morning-breakout/dr00030788. Last accessed February 16, 2023.
23. Montgomery JP, Mokotoff ED, Gentry AC, et al. The extent of bisexual behaviour in HIV-infected men and implications for transmission to their female sex partners.AIDS Care.2003;15:829-837.
24. Bond L, Wheeler DP, Millett GA, LaPollo AB, Carson LF, Liau A. Black men who have sex with men and the association of down-low identity with HIV risk behavior.Am J Public Health.2009;99(Suppl 1):S92-S95.
25. McCree DH, Oster AM, Jeffries IV WL, et al. HIV acquisition and transmission among men who have sex with men and women: what we know and how to prevent it.Prevent Med.2017;100:132-134.
26. 26. Centers for Disease Control and Prevention. Ways HIV Can Be Transmitted. Available at https://www.cdc.gov/hiv/basics/hiv-transmission/ways-people-get-hiv.html?. Last accessed February 16, 2023.
27. Centers for Disease Control and Prevention. HIV transmission through transfusion—Missouri and Colorado, 2008.MMWR.2010;59(41):1335-1339.
28. Centers for Disease Control and Prevention. Summary of Information on The Safety and Effectiveness of Syringe Services Programs (SSPs). Available athttps://www.cdc.gov/ssp/syringe-services-programs-summary.html#. Last accessed February 16, 2023.
29. Centers for Disease Control and Prevention. Syringe Disinfection for Injection Drug Users. Available athttps://stacks.cdc.gov/view/cdc/31783. Last accessed February 16, 2023.
30. Centers for Disease Control and Prevention. HIV and Perinatal Transmission. Available at https://www.cdc.gov/hiv/group/pregnant-people/index.html? Last accessed February 16, 2023.
31. Henry J. Kaiser Family Foundation. Women and HIV/AIDS in the United States. Available athttps://www.kff.org/hivaids/fact-sheet/women-and-hivaids-in-the-united-states/. Last accessed February 16, 2023.
32. Centers for Disease Control and Prevention. Zidovudine for the prevention of HIV transmission from mother to infant.MMWR.1994;43(16):285-287.
33. 33. Ahn J, Cohen SM. Transmission of human immunodeficiency virus and hepatitis C virus through liver transplantation.Liver Transpl.2008;14(11):1603-1608.
34. Centers for Disease Control and Prevention. HIV transmitted from a living organ donor—New York City, 2009.MMWR.2011;60(10):297-301.
35. Organ Procurement and Transplantation Network. HOPE Act. Available at https://optn.transplant.hrsa.gov/professionals/by-topic/hope-act/. Last accessed February 16, 2023.
36. United Network for Organ Sharing. HOPE Act Impact Continues at Five-Year Milestone. Available athttps://unos.org/news/in-focus/hope-act-impact-continues-at-five-year-milestone/. Last accessed February 16, 2023.
37. Centers for Disease Control and Prevention. Surveillance of Occupationally Acquired HIV/AIDS in Healthcare Personnel, as of December 2010. Available athttps://www.cdc.gov/HAI/organisms/hiv/Surveillance-Occupationally-Acquired-HIV-AIDS.html. Last accessed February 16, 2023.
38. Occupational Safety and Health Administration. Bloodborne Pathogens: Standard Number 1910.1030. Available athttps://www.osha.gov/laws-regs/regulations/standardnumber/1910/1910.1030. Last accessed February 16, 2023.
39. Kuhar DT, Henderson DK, Struble KA, et al. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.Infect Control Hosp Epidemiol.2013;34(9):875-892.
40. Panel on Treatment of HIV During Pregnancy and Prevention of Perinatal Transmission. Recommendations for the Use of Antiretroviral Drugs During Pregnancy and Interventions to Reduce Perinatal HIV Transmission in the United States. Available at https://clinicalinfo.hiv.gov/en/guidelines/perinatal/arv-counseling-guide. Last accessed February 16, 2023.
41. Gandhi RT, Bedimo R, Hoy JF, et al. Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society-USA Panel.JAMA.2023;329(1):63-84.
42. Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings.MMWR.2006;55(RR14):1-17.
43. Papadakis MA, McPhee SJ, Rabow MW (eds).Current Medical Diagnosis and Treatment.59th ed. New York, NY: McGraw-Hill; 2020.
44. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV. Available at https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/adult-adolescent-arv/guidelines-adult-adolescent-arv.pdf. Last accessed February 16, 2023.
45. HIVinfo.NIH.gov. FDA-Approved HIV Medicines. Available at https://hivinfo.nih.gov/understanding-hiv/fact-sheets/fda-approved-hiv-medicines. Last accessed February 16, 2023.
46. 46. U.S. Food and Drug Administration. FDA Approves First Extended-Release, Injectable Drug Regimen for Adults Living with HIV. Available athttps://www.fda.gov/news-events/press-announcements/fda-approves-first-extended-release-injectable-drug-regimen-adults-living-hiv. Last accessed February 16, 2023.
47. U.S. Food and Drug Administration. FDA Approves New HIV Drug for Adults with Limited Treatment Options. Available athttps://www.fda.gov/news-events/press-announcements/fda-approves-new-hiv-drug-adults-limited-treatment-options. Last accessed February 15, 2023.
48. Panel on Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV. Available at https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/adult-adolescent-oi/guidelines-adult-adolescent-oi.pdf. Last accessed February 16, 2023.
49. Jiang T, Liu C, Zhang J, Huang X, Xu J. Impact of the COVID-19 pandemic on the UNAIDS six 95% HIV control targets.Front Med (Lausanne).2022;9:818054.
50. Santos GM, Hong C, Wilson N, et al. Persistent disparities in COVID-19-associated impacts on HIV prevention and care among a global sample of sexual and gender minority individuals.Glob Public Health.2022;17(6):827-842.
51. Centers for Disease Control and Prevention. Health Alert Network. Severe Manifestations of Monkeypox Among People Who Are Immunocompromised Due to HIV or Other Conditions. Available athttps://emergency.cdc.gov/han/2022/han00475.asp. Last accessed February 16, 2023.
52. 52. Bartlett JG, Cheever LW, Johnson MP, Paauw DS (eds).Guide to Primary Care of People with HIV/AIDS.Washington, DC: U.S. Department of Health and Human Services; 2004.
53. Centers for Disease Control and Prevention. HIV and Women. Available athttps://www.cdc.gov/hiv/group/gender/women/index.html. Last accessed February 16, 2023.
54. Centers for Disease Control and Prevention. Update: AIDS among women – United States, 1994.MMWR.1995;44(05):81-84.
55. Selik RM, Mokotoff ED, Branson B, Owen SM, Whitmore S, Hall HI. Revised surveillance case definition for HIV infection—United States, 2014.MMWR.2014;63(RR3):1-10.
56. Centers for Disease Control and Prevention. Leading Causes of Death in Females, United States. Available athttps://www.cdc.gov/women/lcod/index.htm. Last accessed February 16, 2023.
57. Centers for Disease Control and Prevention. HIV and Women: HIV Diagnoses. Available athttps://www.cdc.gov/hiv/group/gender/women/diagnoses.html. Last accessed February 16, 2023.
58. 58. Centers for Disease Control and Prevention. NCHHSTP AtlasPlus. Available athttps://www.cdc.gov/nchhstp/atlas/index.htm. Last accessed February 16, 2023.
60. Notario-Pérez F, Ruiz-Caro R, Veiga-Ochoa MD. Historical development of vaginal microbicides to prevent sexual transmission of HIV in women: from past failures to future hopes.Drug Des Devel Ther.2017;11:1767-1787.
61. National Institute of Allergy and Infectious Diseases. Sex and Gender-Specific Health Challenges Facing Women: HIV/AIDS. Available at https://www.niaid.nih.gov/research/sex-specific-womens-health-challenges. Last accessed February 16, 2023.
62. Liu G, Sharma M, Tan N, Barnabas R. HIV-positive women have higher risk of HPV infection, precancerous lesions, and cervical cancer: a systematic review and meta-analysis.AIDS.2018;32(6):795-808.
63. Minkoff H, Augenbraun M. Antiretroviral therapy for pregnant women.Am J Obstet Gynecol.1997;176:478-89.
64. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. Available at https://npin.cdc.gov/publication/recommendations-use-antiretroviral-drugs-pregnant-hiv-1-infected-women-maternal-health. Last accessed February 16, 2023.
65. Anderson JR (ed).A Guide to the Clinical Care of Women with HIV.Rockville, MD: U.S. Department of Health and Human Services; 2005.
66. U.S. Preventive Services Task Force. Human Immunodeficiency Virus (HIV) Infection: Screening. Available at https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening. Last accessed February 16, 2023.
67. American Academy of Pediatrics Committee on Pediatric AIDS. Policy statement: HIV testing and prophylaxis to prevent mother-to-child transmission in the United States.Pediatrics.2008;122(5):1127-1134.
68. HIV.gov. Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection. Available at https://clinicalinfo.hiv.gov/en/guidelines/pediatric-arv/whats-new#. Last accessed February 16, 2023.
69. Schneider E, Whitmore S, Glynn MK, Dominguez K, Mitsch A, McKenna MT. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years—United States, 2008.MMWR.2008;57(RR10):1-8.
70. 70. MacPherson P, Munthali C, Ferguson J, et al. Service delivery interventions to improve adolescents' linkage, retention and adherence to antiretroviral therapy and HIV care.Trop Med Int Health.2015;20(8):1015-1032.
71. Schneider E, Whitmore S, et al. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years – United Stated, 2008.MMWR.2008;57(RR10):1-8.
72. Selik RM. Mokotoff ED, Branson B, Owen SM, Whitmore S, Hall HI. Revised surveillance case definition for HIV infection – United States, 2014.MMWR.2014;63(RR03):1-10.
74. Centers for Disease Control and Prevention. HIV in the United States by Age. Available at https://www.cdc.gov/hiv/group/age/index.html?. Last accessed February 16, 2023.
75. International Association of Providers of AIDS Care. Older People. Available at https://www.iapac.org/fact-sheet/older-people/. Last accessed February 16, 2023.
77. National Institute on Aging. HIV, AIDS and Older Adults. Available at https://www.nia.nih.gov/health/hiv-aids-and-older-adults. Last accessed February 16, 2023.
80. Dray-Spira R, Persoz A, Boufassa F, et al. Employment loss following HIV infection in the era of highly active antiretroviral therapies.Eur J Public Health.2006;16(1):89-95.
81. Rabkin JG, McElhiney M, Ferrando SJ, Van Gorp W, Lin SH. Predictors of employment of men with HIV/AIDS: a longitudinal study.Psychosom Med.2004;66;72-78.
82. U.S. Department of Labor. HIV/AIDS: HIV and Employment. Available at https://www.dol.gov/agencies/odep/program-areas/hiv-aids. Last accessed February 16, 2023.
84. U.S. Department of Justice, Civil Rights Division. Questions and Answers: The Americans with Disabilities Act and Persons with HIV/AIDS. Available at https://archive.ada.gov/hiv/ada_qa_hiv.htm. Last accessed February 16, 2023.
85. U.S. Department of Health and Human Services. Discrimination on the Basis of Disability. Available athttps://www.hhs.gov/civil-rights/for-individuals/disability/index.html. Last accessed February 16, 2023.
87. Carrese J, Rhodes L. Western bioethics on the Navaho reservation: benefit or harm?JAMA.1995;274:826-829.
88. 88. Rashad AM, MacVane Phipps F, Haith-Cooper M. Obtaining informed consent in an Egyptian research study.Nursing Ethics.2004;11(4):394-399.
89. Yick A, Berthold SM. Conducting research on violence in Asian American communities: methodological issues.Violence Victims.2005;20(6):661-677.
90. U.S. Food and Drug Administration. Truvada for PrEP Fact Sheet: Ensuring Safe a Proper Use. Available athttps://www.fda.gov/media/83586/download. Last accessed February 16, 2023.
91. U.S. Food and Drug Administration. FDA Approves Second Drug to Prevent HIV Infection as Part of Ongoing Efforts to End the HIV Epidemic. Available athttps://www.fda.gov/news-events/press-announcements/fda-approves-second-drug-prevent-hiv-infection-part-ongoing-efforts-end-hiv-epidemic. Last accessed February 16, 2023.
92. U.S. Food and Drug Administration. FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention. Available athttps://www.fda.gov/news-events/press-announcements/fda-approves-first-injectable-treatment-hiv-pre-exposure-prevention. Last accessed February 16, 2023.
93. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.N Engl J Med.2010;363:2587-2599.
94. Centers for Disease Control and Prevention. Preexposure Prophylaxis for the Prevention of HIV Infection in the United States, 2021 Update. Available athttps://www.cdc.gov/hiv/pdf/risk/prep/cdc-hiv-prep-guidelines-2021.pdf. Last accessed February 16, 2023.
95. 95. HIV.gov. HIV Vaccines. Available at https://www.hiv.gov/hiv-basics/hiv-prevention/potential-future-options/hiv-vaccines. Last accessed February 16, 2023.
96. International AIDS Vaccine Initiative. IAVI and Partners Initiate Early Clinical Study of New Strategy to Help Prevent HIV. Available athttps://www.iavi.org/newsroom/press-releases/2014/iavi-and-partners-initiate-early-clinical-study-of-new-strategy-to-help-prevent-hiv. Last accessed February 16, 2023.
99. Underwood J, Brener N, Thornton J, et al. Youth Risk Behavior Surveillance—United States, 2019.MMWR.2020;69(S1):1-83.
100. Centers for Disease Control and Prevention. Trends in HIV-related risk behaviors among high school students—United States, 1991–2011.MMWR.2012;61(29):556-560.
101. 101. American Academy of Pediatrics Committee on Psychosocial Aspects of Child and Family Health and Committee on Adolescence. Sexuality education for children and adolescents.Pediatrics.2016;138(2):e1-e11.
102. Centers for Disease Control and Prevention. HIV/AIDS Prevention Research Synthesis Project. Available athttps://www.cdc.gov/hiv/dhap/prb/prs/index.html. Last accessed February 16, 2023.
103. Herbst JH, Jacobs ED, Finlayson TJ, et al. Estimating HIV prevalence and risk behaviors of transgender persons in the United States: a systematic review.AIDS Behav.2008;12(1):1-17.
104. Human Rights Campaign. Transgender People and HIV: What We Know. Available at https://www.hrc.org/resources/transgender-people-and-hiv-what-we-know. Last accessed February 16, 2023.
105. Centers for Disease Control and Prevention. Issue Brief: HIV and Transgender Communities. Available at https://www.cdc.gov/hiv/policies/data/transgender-issue-brief.html. Last accessed February 16, 2023.
106. Edwards JW, Fisher DG, Reynolds GL. Male-to-female transgender and transsexual clients of HIV service programs in Los Angeles County, California.Am J Public Health.2007;97(6):1030-1033.
107. Centers for Disease Control and Prevention. HIV Among Transgender People. Available at https://www.cdc.gov/hiv/group/gender/transgender/index.html. Last accessed February 16, 2023.
108. Grant JM, Mottet LA, Tanis J, Harrison J, Herman JL, Keisling M. Injustice at Every Turn: A Report of the National Transgender Discrimination Survey. Available at https://www.thetaskforce.org/injustice-every-turn-report-national-transgender-discrimination-survey. Last accessed February 16, 2023.
109. Centers for Disease Control and Prevention. HIV Testing, Prevention and Care for Transgender People. Available at https://www.cdc.gov/hiv/clinicians/transforming-health/health-care-providers/prevention-and-care-data.html. Last accessed February 16, 2023.
1. Panel on Antiretroviral Guidelines for Adults and Adolescents.Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Bethesda, MD: Department of Health and Human Services; 2022. Available at https://clinicalinfo.hiv.gov/sites/default/files/guidelines/documents/adult-adolescent-arv/guidelines-adult-adolescent-arv.pdf. Last accessed February 3, 2023.
2. U.S. Preventive Services Task Force. Screening for HIV infection: U.S. Preventive Services Task Force Recommendation Statement.JAMA. 2019;321(23):2326-2336. Available at https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/human-immunodeficiency-virus-hiv-infection-screening. Last accessed February 23, 2023.
Mention of commercial products does not indicate endorsement.